Patents Assigned to Korean Advanced Insititute of Science and Technology (KAIST)
  • Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein
    Patent number: 9856462
    Abstract: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide comprising a nucleotide sequence encoding a VEGFR1 component.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: January 2, 2018
    Assignees: Korean Advanced Insititute of Science and Technology (KAIST), Seoul National University Bundang Hospital
    Inventors: Ho Min Kim, Hye Kyoung Hong, Se Joon Woo, Eun-Jin Lim, Kyu Hyung Park